4-[[(4-Fluorophenyl)imino]methyl]-phenol CAS 3382-63-6 Ezetimibe Intermediate Purity ≥99.0% Hoobkas
Chaw tsim khoom muab khoom;High Quality thiab Competitive Nqe
Kev Lag Luam Supply Ezetimibe (CAS: 163222-33-1) Cov Neeg Nruab Nrab:
(S)-(+)-4-Phenyl-2-oxazolidinone CAS: 99395-88-7
(R)-(+)-2-Methyl-CBS-oxazaborolidine CAS: 112022-83-0
4- (4-Fluorobenzoyl) butyric acid CAS: 149437-76-3
4-[[(4-Fluorophenyl)imino]methyl]-phenol CAS: 3382-63-6
N-(4-(Benzyloxy)benzylidene)-4-fluoroaniline CAS: 70627-52-0
(3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one CAS: 190595-65 -4
(4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone CAS: 189028-93-1
(4S)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one CAS: 189028-95-3
CAS Nr .: 163222-33-1
Tshuaj npe | 4-[[(4-Fluorophenyl)imino]methyl]-phenol |
CAS Nr | 3382-63-6 |
CAT Number | Qauv: RF-PI145 |
Tshuag xwm txheej | Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons |
Molecular Formula | C13H10FNO |
Molecular Luj | 215.22 Nws |
Melting Point | 179.0 txog 183.0 ℃ |
Hom | Ruifu Tshuaj |
Yam khoom | Specifications |
Qhov tshwm sim | Off-White rau Dawb Hmoov |
Purity / Analysis Method | ≥99.0% (HPLC) |
Poob rau ziab | ≤0.50% |
Ib leeg Impurity | ≤0.50% |
Tag nrho cov impurities | ≤ 1.0% |
Hnyav Hlau | ≤ 20ppm |
Test Standard | Enterprise Standard |
Kev siv | Ezetimibe (CAS: 163222-33-1) Intermediate |
Pob: Lub raj mis, Aluminium ntawv ci hnab, Cardboard nruas, 25kg / Nruas, los yog raws li tus neeg yuav tsum tau muaj.
Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb, noo noo thiab kab tsuag.
Shanghai Ruifu Chemical Co., Ltd. yog cov chaw tsim khoom thiab cov chaw muag khoom ntawm 4-[[(4-Fluorophenyl) imino]methyl]-phenol (CAS: 3382-63-6) nrog cov khoom zoo, nws yog ib qho nruab nrab ntawm Ezetimibe ( CAS: 163222-33-1 Nr.Ezetimibe yog cov tshuaj ananti-hyperlipidemic siv los txo qis cov roj cholesterol hauv cov ntshav.Ezetimibe yog ib qho cholesterol thauj khoom inhibitor uas khi rau NPC1L1.Nws tau qhia tias yog kev kho mob ntxiv rau kev noj zaub mov kom txo tau cov qib siab tag nrho-C, LDL-C, thiab ApoB hauv cov neeg mob uas muaj kev mob hnyav (heterozygous tsev neeg thiab tsis tsev neeg) hypercholesterolemia.